Drug Profile
Research programme: biodefence vaccines - iBio
Alternative Names: Anthrax and plague vaccine - iBio; Biodefense vaccines - iBioLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator iBio Inc
- Class Anthrax vaccines; Plague vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anthrax; Plague
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Anthrax in USA (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Plague in USA (PO)
- 18 Oct 2016 iBio has patent protection for iBioModulator™ thermostable immunomodulator protein technology in Canada